Literature DB >> 12223180

Abrogation of bleomycin-induced lung fibrosis by nitric oxide synthase inhibitor, aminoguanidine in mice.

S N Giri1, I Biring, T Nguyen, Q Wang, D M Hyde.   

Abstract

The effects of aminoguanidine (AG), a specific inhibitor of inducible nitric oxide synthase, on the bleomycin (BL)-induced lung fibrosis was evaluated in mice. The animals were placed into five groups: saline (SA)-instilled drinking water (SA+H(2)O), saline-instilled drinking water containing 0.5%AG (SA+0.5%AG), BL-instilled drinking water (BL+H(2)O), BL-instilled drinking water containing 0.2%AG (BL+0.2%AG), and BL-instilled drinking water containing 0.5%AG (BL+0.5%AG). The mice had free access to H(2)O or H(2)O containing AG and lab chow ad lib 2 days prior to intratracheal (IT) instillation of BL (0.07U/mouse/100 microL) or an equivalent volume of sterile isotonic saline. The mice in the SA+0.5%AG group consumed the greatest amount of AG without any ill effects than the mice in any other group. There were no differences in any of the measured biochemical determinants between the SA+H(2)O and SA+0.5%AG control groups. The IT instillation of BL in the BL+H(2)O group caused significant increases in the lipid peroxidation, hydroxyproline content, and prolyl hydroxylase activity of lungs and influx of inflammatory cells in the broncheoalveolar lavage fluid (BALF) as compared to both control groups. The intake of aminoguanidine by mice in the BL+0.5%AG group caused significant reductions in the BL-induced increases in all measured biochemical indices of lung fibrosis without any effects on the influx of inflammatory cells in the BALF. In fact, AG in both BL-treated groups additionally increased the total cell counts in the BALF from mice in the BL+0.2%AG and BL+0.5%AG groups as compared to the BL+H(2)O group. Histopathological evaluation of the lungs revealed that the mice in the BL+0.5%AG group had markedly fewer fibrotic lesions than mice in the BL+H(2)O group. These results demonstrate that aminoguanidine minimizes the BL-induced lung fibrosis at both the biochemical and the morphological level and support our earlier hypothesis that the production of nitric oxide plays a significant role in the pathogenesis lung fibrosis caused by BL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12223180     DOI: 10.1016/s1089-8603(02)00102-7

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  14 in total

Review 1.  Mechanisms and interventions in peritoneal fibrosis.

Authors:  Yasuhiko Tomino
Journal:  Clin Exp Nephrol       Date:  2011-09-21       Impact factor: 2.801

2.  Effects of erdosteine on bleomycin-induced lung fibrosis in rats.

Authors:  Haşim Boyaci; Hale Maral; Gupse Turan; Ilknur Başyiğit; Meltem O Dillioğlugil; Füsun Yildiz; Melih Tugay; Ayşe Pala; Cengiz Erçin
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

Review 3.  Macrophages and inflammatory mediators in pulmonary injury induced by mustard vesicants.

Authors:  Rama Malaviya; Vasanthi R Sunil; Alessandro Venosa; Kinal N Vayas; Rita Businaro; Diane E Heck; Jeffrey D Laskin; Debra L Laskin
Journal:  Ann N Y Acad Sci       Date:  2016-06-28       Impact factor: 5.691

4.  Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Resat Cinar; Bernadette R Gochuico; Malliga R Iyer; Tony Jourdan; Tadafumi Yokoyama; Joshua K Park; Nathan J Coffey; Hadass Pri-Chen; Gergő Szanda; Ziyi Liu; Ken Mackie; William A Gahl; George Kunos
Journal:  JCI Insight       Date:  2017-04-20

Review 5.  Inflammatory mechanisms of pulmonary injury induced by mustards.

Authors:  Rama Malaviya; Vasanthi R Sunil; Alessandro Venosa; Kinal N Vayas; Diane E Heck; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Lett       Date:  2015-10-23       Impact factor: 4.372

6.  Protective and therapeutic effect of molsidomine on bleomycin-induced lung fibrosis in rats.

Authors:  Talat Kilic; Hakan Parlakpinar; Alaadin Polat; Elif Taslidere; Nigar Vardi; Ediz Sarihan; Hilal Ermis; Kevser Tanbag
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

7.  The role of inducible nitric oxide synthase for interstitial remodeling of alveolar septa in surfactant protein D-deficient mice.

Authors:  Lars Knudsen; Elena N Atochina-Vasserman; Christopher B Massa; Bastian Birkelbach; Chang-Jiang Guo; Pamela Scott; Beat Haenni; Michael F Beers; Matthias Ochs; Andrew J Gow
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-08-28       Impact factor: 5.464

8.  Attenuation of acute nitrogen mustard-induced lung injury, inflammation and fibrogenesis by a nitric oxide synthase inhibitor.

Authors:  Rama Malaviya; Alessandro Venosa; Leroy Hall; Andrew J Gow; Patrick J Sinko; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2012-09-06       Impact factor: 4.219

Review 9.  Taurine and its chloramine: modulators of immunity.

Authors:  Georgia B Schuller-Levis; Eunkyue Park
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

Review 10.  The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

Authors:  Antje Moeller; Kjetil Ask; David Warburton; Jack Gauldie; Martin Kolb
Journal:  Int J Biochem Cell Biol       Date:  2007-08-30       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.